Home
Live Updates
Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook : comparemela.com
Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook
2022 objectives successfully met, notably in the development of the two drug candidates: AEF0117: phase 2b study in the United States progressing as expected AEF0217: the compound's
Related Keywords
Spain ,
United States ,
Paris ,
France General ,
France ,
Barcelona ,
Comunidad Autonoma De Cataluna ,
Spanish ,
American ,
Frances Levin ,
Arthur Rouill ,
Vincenzo Piazza ,
Torre Fornell ,
Daelis Farma ,
Magendie Neurocenter ,
Columbia University ,
Research Development ,
Research Tax Credit ,
Spanish Agency Of Medicines ,
Hospital Del Mar Medical Research Institute ,
Inserm Transfert Initiative ,
Euronext ,
Linkedin ,
Twitter ,
Initial Public ,
Euronext Paris ,
Nouvelle Aquitaine Region ,
North American National Institute ,
Drug Abuse ,
National Institute ,
Spanish Agency ,
Medical Products ,
Rafael De La Torre Fornell ,
Signaling Specific ,
Pier Vincenzo Piazza ,
Down Syndrome ,
Des March ,
Saelis ,
Sarma ,
Reports ,
022 ,
Nnual ,
Financial ,
Results ,
Onfirms ,
023 ,
Outlook ,
comparemela.com © 2020. All Rights Reserved.